Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philippe Ravaud

Showing results (251-260 of 501) with videos related to

Pageof 51
Sort By:
Annals of Surgery|October 8, 2013
Comparison of treatment effect estimates from prospective nonrandomized studies with propensity score analysis and randomized controlled trials of surgical proceduresGuillaume Lonjon, Isabelle Boutron, Ludovic Trinquart, et al.
Scientific Reports|August 2, 2017
Evidence for Treatment-by-Biomarker interaction for FDA-approved Oncology Drugs with Required Pharmacogenomic Biomarker TestingAlexandre Vivot, Isabelle Boutron, Geoffroy Béraud-Chaulet, et al.
BMJ Open|November 20, 2017
Interpretation of health news items reported with or without spin: protocol for a prospective meta-analysis of 16 randomised controlled trialsRomana Haneef, Amélie Yavchitz, Philippe Ravaud, et al.
JAMA Internal Medicine|October 20, 2020
Effect of Tocilizumab vs Usual Care in Adults Hospitalized With COVID-19 and Moderate or Severe Pneumonia: A Randomized Clinical TrialOlivier Hermine, Xavier Mariette, Pierre-Louis Tharaux, et al.
Plos Medicine|September 18, 2012
Misrepresentation of randomized controlled trials in press releases and news coverage: a cohort studyAmélie Yavchitz, Isabelle Boutron, Aida Bafeta, et al.
The European Respiratory Journal|July 27, 2022
Reply: COVID-19 drug research and the cohort multiple randomised controlled trial designRaphaël Porcher, Philippe Ravaud, Matthieu Resche-Rigon, et al.
Journal of Clinical Epidemiology|April 30, 2026
A scoping review of ICHOM Sets identifies a small number of commonly recommended baseline characteristicsMelanie Salman, Viet-Thi Tran, Isabelle Boutron, et al.
Annals of Surgery|March 28, 2014
Reply to Letter: "Equivalence Approach Is More Appropriate for Comparison of Treatment Effect Estimates"Guillaume Lonjon, Isabelle Boutron, Ludovic Trinquart, et al.
Journal of Clinical Epidemiology|December 29, 2022
Considering multiple outcomes with different weights informed the hierarchy of interventions in network meta-analysisDimitris Mavridis, Adriani Nikolakopoulou, Irini Moustaki, et al.
Digital Health|July 3, 2026
Heterogeneity of information across seven curated national or international digital health app repositoriesViet-Thi Tran, Philippe Ravaud, Marleen Kunneman, et al.
Pageof 51

Showing results (251-260 of 501) with videos related to

Sort By:
Pageof 51
Annals of Surgery|October 8, 2013
Comparison of treatment effect estimates from prospective nonrandomized studies with propensity score analysis and randomized controlled trials of surgical proceduresGuillaume Lonjon, Isabelle Boutron, Ludovic Trinquart, et al.
Scientific Reports|August 2, 2017
Evidence for Treatment-by-Biomarker interaction for FDA-approved Oncology Drugs with Required Pharmacogenomic Biomarker TestingAlexandre Vivot, Isabelle Boutron, Geoffroy Béraud-Chaulet, et al.
BMJ Open|November 20, 2017
Interpretation of health news items reported with or without spin: protocol for a prospective meta-analysis of 16 randomised controlled trialsRomana Haneef, Amélie Yavchitz, Philippe Ravaud, et al.
JAMA Internal Medicine|October 20, 2020
Effect of Tocilizumab vs Usual Care in Adults Hospitalized With COVID-19 and Moderate or Severe Pneumonia: A Randomized Clinical TrialOlivier Hermine, Xavier Mariette, Pierre-Louis Tharaux, et al.
Plos Medicine|September 18, 2012
Misrepresentation of randomized controlled trials in press releases and news coverage: a cohort studyAmélie Yavchitz, Isabelle Boutron, Aida Bafeta, et al.
The European Respiratory Journal|July 27, 2022
Reply: COVID-19 drug research and the cohort multiple randomised controlled trial designRaphaël Porcher, Philippe Ravaud, Matthieu Resche-Rigon, et al.
Journal of Clinical Epidemiology|April 30, 2026
A scoping review of ICHOM Sets identifies a small number of commonly recommended baseline characteristicsMelanie Salman, Viet-Thi Tran, Isabelle Boutron, et al.
Annals of Surgery|March 28, 2014
Reply to Letter: "Equivalence Approach Is More Appropriate for Comparison of Treatment Effect Estimates"Guillaume Lonjon, Isabelle Boutron, Ludovic Trinquart, et al.
Journal of Clinical Epidemiology|December 29, 2022
Considering multiple outcomes with different weights informed the hierarchy of interventions in network meta-analysisDimitris Mavridis, Adriani Nikolakopoulou, Irini Moustaki, et al.
Digital Health|July 3, 2026
Heterogeneity of information across seven curated national or international digital health app repositoriesViet-Thi Tran, Philippe Ravaud, Marleen Kunneman, et al.
Pageof 51